SCHEMBL24676460

SCHEMBL24676460

CC(C)(C)OC(=O)N(c1nc(C(F)(F)F)c(Br)s1)C1CCCC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676475 0.85 RAB9A (0.34) RAB9A
SCHEMBL29754868 0.80 PAX8 (0.37)
SCHEMBL24676815 0.75 AAK1 (0.35)
SCHEMBL29019239 0.73 MEN1 (0.31)
SCHEMBL30186673 0.69 ALDH1A1 (0.34)
SCHEMBL22832375 0.69 PPARA (0.44) RAB9A
SCHEMBL24675956 0.68
SCHEMBL24676959 0.68 DDB1 (0.37)
SCHEMBL30070539 0.66 MEN1 (0.40)
SCHEMBL27928340 0.66 CHRM2 (0.42) RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed